Mortality in Dravet syndrome: A review

Epilepsy and Behavior

Volumn 64, Issue , 2016, Pages 69-74

  Shmuely, Sharon ^a,b,c   Sisodiya, Sanjay M ^b,c   Gunning, W Boudewijn ^a,d   Sander, Josemir W ^a,b,c   Thijs, Roland D ^a,b,c,e  

^a STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c EPILEPSY SOCIETY   (United Kingdom)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Dravet; SCN1A; Status epilepticus; Sudden unexpected death in epilepsy

Indexed keywords

ACCIDENTAL DEATH; AGE; CAUSE OF DEATH; DROWNING; EPILEPTIC STATE; HUMAN; INFECTION; PREMATURE MORTALITY; REVIEW; SEVERE MYOCLONIC EPILEPSY IN INFANCY; SUDDEN DEATH; SYSTEMATIC REVIEW; CHILD; MORTALITY; MYOCLONUS EPILEPSY;

CHILD; DEATH, SUDDEN; EPILEPSIES, MYOCLONIC; HUMANS;

EID: 84991490154     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2016.09.007     Document Type: Review

References (55)

1. [1] Dravet, C., Les épilepsies graves de l'enfant. Vie Med 8 (1978), 543–548.
2. [2] Depienne, C., Trouillard, O., Saint-Martin, C., Gourfinkel-An, I., Bouteiller, D., Carpentier, W., et al. Spectrum of SCN1A gene mutations associated with Dravet syndrome: analysis of 333 patients. J Med Genet 46 (2009), 183–191.
3. [3] Djémié, T., Weckhuysen, S., von Spiczak, S., Carvill, G.L., Jaehn, J., Anttonen, A.K., et al. Pitfalls in genetic testing: the story of missed SCN1A mutations. Mol Genet Genomics, 2016, 10.1002/mgg3.217.
4. [4] Bayat, A., Hjalgrim, H., Moller, R.S., The incidence of SCN1A-related Dravet syndrome in Denmark is 1:22,000: a population-based study from 2004 to 2009. Epilepsia 56 (2015), 36–39.
5. [5] Brunklaus, A., Ellis, R., Reavey, E., Forbes, G.H., Zuberi, S.M., Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome. Brain 135 (2012), 2329–2336.
6. [6] Hurst, D.L., Epidemiology of severe myoclonic epilepsy of infancy. Epilepsia 31 (1990), 397–400.
7. [7] Yakoub, M., Dulac, O., Jambaqué, I., Chiron, C., Plouin, P., Early diagnosis of severe myoclonic epilepsy in infancy. Brain Dev 14 (1992), 299–303.
8. [8] Dravet, C., Dravet syndrome history. Dev Med Child Neurol 53 (2011), 1–6.
9. [9] Dravet, C., Bureau, M., Oguni, H., Fukuyama, Y., Cokar, O., Severe myoclonic epilepsy in infancy: Dravet syndrome. Adv Neurol 95 (2005), 71–102.
10. [10] Genton, P., Velizarova, R., Dravet, C., Dravet syndrome: the long-term outcome. Epilepsia 52 (2011), 44–49.
11. [11] Jansen, F.E., Sadleir, L.G., Harkin, L.A., Vadlamudi, L., McMahon, J.M., Mulley, J.C., et al. Severe myoclonic epilepsy of infancy (Dravet syndrome): recognition and diagnosis in adults. Neurology 67 (2006), 2224–2226.
12. [12] Sakauchi, M., Oguni, H., Kato, I., Osawa, M., Hirose, S., Kaneko, S., et al. Retrospective multiinstitutional study of the prevalence of early death in Dravet syndrome. Epilepsia 52 (2011), 1144–1149.
13. [13] Bagnall, R.D., Crompton, D.E., Petrovski, S., Lam, L., Cutmore, C., Garry, S.I., et al. Exome-based analysis of cardiac arrhythmia, respiratory control, and epilepsy genes in sudden unexpected death in epilepsy. Ann Neurol 79 (2016), 522–534.
14. [14] Leu, C., Balestrini, S., Maher, B., Hernández-Hernández, L., Gormley, P., Hämäläinen, E., et al. Genome-wide polygenic burden of rare deleterious variants in sudden unexpected death in epilepsy. EBioMedicine 2 (2015), 1063–1070.
15. [15] Levac, D., Colquhoun, H., O'Brien, K.K., Scoping studies: advancing the methodology. Implement Sci, 5, 2010, 69.
16. [16] Nashef, L., So, E.L., Ryvlin, P., Tomson, T., Unifying the definitions of sudden unexpected death in epilepsy. Epilepsia 53 (2012), 227–233.
17. [17] Okumura, A., Uematsu, M., Imataka, G., Tanaka, M., Okanishi, T., Kubota, T., et al. Acute encephalopathy in children with Dravet syndrome. Epilepsia 53 (2012), 79–86.
18. [18] Hauser, W.A., Annegers, J.F., Elveback, L.R., Mortality in patients with epilepsy. Epilepsia 21 (1980), 399–412.
19. [19] Neligan, A., Bell, G.S., Johnson, A.L., Goodridge, D.M., Shorvon, S.D., Sander, J.W., The long-term risk of premature mortality in people with epilepsy. Brain 134 (2011), 388–395.
20. [20] Tomson, T., Beghi, E., Sundqvist, A., Johannessen, S.I., Medical risks in epilepsy: a review with focus on physical injuries, mortality, traffic accidents and their prevention. Epilepsy Res 60 (2004), 1–16.
21. [21] Kaiboriboon, K., Schiltz, N.K., Bakaki, P.M., Lhatoo, S.D., Koroukian, S.M., Premature mortality in poor health and low income adults with epilepsy. Epilepsia 55 (2014), 1781–1788.
22. [22] Leestma, J.E., Annegers, J.F., Brodie, M.J., Brown, S., Schraeder, P., Siscovick, D., et al. Sudden unexplained death in epilepsy: observations from a large clinical development program. Epilepsia 38 (1997), 47–55.
23. [23] Nashef, L., Fish, D.R., Garner, S., Sander, J.W., Shorvon, S.D., Sudden death in epilepsy: a study of incidence in a young cohort with epilepsy and learning difficulty. Epilepsia 36 (1995), 1187–1194.
24. [24] Racoosin, J.A., Feeney, J., Burkhart, G., Boehm, G., Mortality in antiepileptic drug development programs. Neurology 56 (2001), 514–519.
25. [25] Koubeissi, M., Alshekhlee, A., In-hospital mortality of generalized convulsive status epilepticus: a large US sample. Neurology 69 (2007), 886–893.
26. [26] Wu, Y.W., Shek, D.W., Garcia, P.A., Zhao, S., Johnston, S.C., Incidence and mortality of generalized convulsive status epilepticus in California. Neurology 58 (2002), 1070–1076.
27. [27] Ficker, D.M., So, E.L., Shen, W.K., Annegers, J.F., O'Brien, P.C., Cascino, G.D., et al. Population-based study of the incidence of sudden unexplained death in epilepsy. Neurology 51 (1998), 1270–1274.
28. [28] Jick, S.S., Cole, T.B., Mesher, R.A., Tennis, P., Jick, H., Sudden unexplained death in young persons with primary epilepsy. Pharmacoepidemiol Drug Saf 1 (1992), 59–64.
29. [29] Walczak, T.S., Leppik, I.E., D'Amelio, M., Rarick, J., So, E., Ahman, P., et al. Incidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study. Neurology 56 (2001), 519–525.
30. [30] Clark, D., Riney, K., A population-based post mortem study of sudden unexpected death in epilepsy. J Clin Neurosci 23 (2016), 58–62.
31. [31] Tellez-Zenteno, J.F., Ronquillo, L.H., Wiebe, S., Sudden unexpected death in epilepsy: evidence-based analysis of incidence and risk factors. Epilepsy Res 65 (2005), 101–115.
32. [32] Thurman, D.J., Hesdorffer, D.C., French, J.A., Sudden unexpected death in epilepsy: assessing the public health burden. Epilepsia 55 (2014), 1479–1485.
33. [33] Mohanraj, R., Norrie, J., Stephen, L.J., Kelly, K., Hitiris, N., Brodie, M.J., Mortality in adults with newly diagnosed and chronic epilepsy: a retrospective comparative study. Lancet Neurol 5 (2006), 481–487.
34. [34] Liebenthal, J.A., Wu, S., Rose, S., Ebersole, J.S., Tao, J.X., Association of prone position with sudden unexpected death in epilepsy. Neurology 84 (2015), 703–709.
35. [35] Lamberts, R.J., Thijs, R.D., Laffan, A., Langan, Y., Sander, J.W., Sudden unexpected death in epilepsy: people with nocturnal seizures may be at highest risk. Epilepsia 53 (2012), 253–257.
36. [36] Hesdorffer, D.C., Tomson, T., Benn, E., Sander, J.W., Nilsson, L., Langan, Y., et al. Combined analysis of risk factors for SUDEP. Epilepsia 52 (2011), 1150–1159.
37. [37] Langan, Y., Nashef, L., Sander, J.W., Sudden unexpected death in epilepsy: a series of witnessed deaths. J Neurol Neurosurg Psychiatry 68 (2000), 211–213.
38. [38] Devinsky, O., Hesdorffer, D.C., Thurman, D.J., Lhatoo, S., Richerson, G., Sudden unexpected death in epilepsy: epidemiology, mechanisms, and prevention. Lancet Neurol 15 (2016), 1075–1088.
39. [39] Surges, R., Sander, J.W., Sudden unexpected death in epilepsy: mechanisms, prevalence, and prevention. Curr Opin Neurol 25 (2012), 201–207.
40. [40] Akiyama, M., Kobayashi, K., Yoshinaga, H., Ohtsuka, Y., A long-term follow-up study of Dravet syndrome up to adulthood. Epilepsia 51 (2010), 1043–1052.
41. [41] Takayama, R., Fujiwara, T., Shigematsu, H., Imai, K., Takahashi, Y., Yamakawa, K., et al. Long-term course of Dravet syndrome: a study from an epilepsy center in Japan. Epilepsia 55 (2014), 528–538.
42. [42] Hesdorffer, D.C., Logroscino, G., Cascino, G., Annegers, J.F., Hauser, W.A., Incidence of status epilepticus in Rochester, Minnesota, 1965–1984. Neurology 50 (1998), 735–741.
43. [43] Auerbach, D.S., Jones, J., Clawson, B.C., Offord, J., Lenk, G.M., Ogiwara, I., et al. Altered cardiac electrophysiology and SUDEP in a model of Dravet syndrome. PLoS One, 8, 2013, e77843.
44. [44] Cheah, C.S., Yu, F.H., Westenbroek, R.E., Kalume, F.K., Oakley, J.C., Potter, G.B., et al. Specific deletion of NaV1.1 sodium channels in inhibitory interneurons causes seizures and premature death in a mouse model of Dravet syndrome. Proc Natl Acad Sci U S A 109 (2012), 14646–14651.
45. [45] Kalume, F., Westenbroek, R.E., Cheah, C.S., Yu, F.H., Oakley, J.C., Scheuer, T., et al. Sudden unexpected death in a mouse model of Dravet syndrome. J Clin Invest 123 (2013), 1798–1808.
46. [46] Yu, F.H., Mantegazza, M., Westenbroek, R.E., Robbins, C.A., Kalume, F., Burton, K.A., et al. Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat Neurosci 9 (2006), 1142–1149.
47. [47] Delogu, A.B., Spinelli, A., Battaglia, D., Dravet, C., De Nisco, A., Saracino, A., et al. Electrical and autonomic cardiac function in patients with Dravet syndrome. Epilepsia 52 (2011), 55–58.
48. [48] Ergul, Y., Ekici, B., Tatli, B., Nisli, K., Ozmen, M., QT and P wave dispersion and heart rate variability in patients with Dravet syndrome. Acta Neurol Belg 113 (2013), 161–166.
49. [49] Goldman, A.M., Behr, E.R., Semsarian, C., Bagnall, R.D., Sisodiya, S., Cooper, P.N., Sudden unexpected death in epilepsy genetics: molecular diagnostics and prevention. Epilepsia 57 (2016), 17–25.
50. [50] Hindocha, N., Nashef, L., Elmslie, F., Birch, R., Zuberi, S., Al-Chalabi, A., et al. Two cases of sudden unexpected death in epilepsy in a GEFS + family with an SCN1A mutation. Epilepsia 49 (2008), 360–365.
51. [51] Tu, E., Bagnall, R.D., Duflou, J., Semsarian, C., Post-mortem review and genetic analysis of sudden unexpected death in epilepsy (SUDEP) cases. Brain Pathol 21 (2011), 201–208.
52. [52] Catarino, C.B., Liu, J.Y., Liagkouras, I., Gibbons, V.S., Labrum, R.W., Ellis, R., et al. Dravet syndrome as epileptic encephalopathy: evidence from long-term course and neuropathology. Brain 134 (2011), 2982–3010.
53. [53] Verbeek, N.E., van Kempen, M., Gunning, W.B., Renier, W.O., Westland, B., Lindhout, D., et al. Adults with a history of possible Dravet syndrome: an illustration of the importance of analysis of the SCN1A gene. Epilepsia 52 (2011), 23–25.
54. [54] Dravet, C., Guerrini, R., Giraud, N., Severe myoclonic epilepsy in infants. Roger, J., Bureau, M., Dravet, C., et al. (eds.) Epileptic syndromes in infancy, childhood and adolescence, 2nd edn, 1992, John Libbey & Company Ltd., London, 75–88.
55. [55] Verbeek, N.E., van der Maas, N.A., Sonsma, A.C., Ippel, E., Vermeer-de Bondt, P.E., Hagebeuk, E., et al. Effect of vaccinations on seizure risk and disease course in Dravet syndrome. Neurology 85 (2015), 596–603.